Enhancing inhibitory effect in SMMC-7721 hepatoma cells through combined treatment of gallic acid and hUC-MSCs-Exos
International Immunopharmacology · 2025
DOI: 10.1016/j.intimp.2024.113704 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Qiang Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Liaoning University of Traditional Chinese Medicine, Liaoning Dalian China. Hauptthemen laut MEDLINE: Gallic Acid, Carcinoma, Hepatocellular, Liver Neoplasms, Apoptosis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Scientific Research Fund of Liaoning Provincial Education Department, Department of Education of Liaoning Province.
Abstract (Originalsprache)
BACKGROUND: Clinically, hepatoma patients are more frequently encountered in the intermediate and advanced stages. Consequently, the majority of patients miss out on the chance to undergo liver transplantation or radical surgery. Radiotherapy and chemotherapy often fall short of delivering satisfactory outcomes. The incidence and mortality rates for liver cancer approach nearly 100%. In recent years, both exosomes (Exos) and natural chemical compounds have demonstrated robust anti-cancer properties; however, the synergistic effect of their combination remains unexplored. METHODS: Exos were extracted from human umbilical cord mesenchymal stem cells (hUC-MSCs). The impact of gallic acid (GA), hUC-MSCs-Exos, and their combined administration on the proliferation inhibition rate and apoptosis of SMMC-7721 hepatoma cells was assessed to ascertain the efficacy differences before and after the combined treatment. A combination of cells metabolomics and network pharmacology techniques was employed to investigate the underlying mechanisms of action. The pivotal targets associated with glycolysis, inflammation, and oxidative stress pathways were confirmed through ELISA assays. RESULTS: The findings elucidate that GA profoundly impedes the proliferation of SMMC-7721 hepatoma cells and instigates apoptotic processes therein. While the impact of hUC-MSCs-Exos alone was inconspicuous, a notable augmentation in effect ensued upon their combined application. Concomitantly, a marked reduction was observed in the expressionlevels of key enzymes including HK, PFK, PK, LDH, TNF-α, IL-1β, CAT, SOD and GSH-Px in the malignant hepatocytes, while IL-6 and MDA exhibited heightened expression. Pathway enrichment analysis underscored selenocompound metabolism and cysteine and methionine metabolism as pivotal pathways. CONCLUSION: The potentiated efficacy of GA conjunction with hUC-MSCs-Exos may be attributed to their synergistic modulation of anti-inflammatory, antioxidant, and glycolytic functions, thereby influencing selenocompound metabolism and cysteine and methionine metabolism. This study reveals the efficacy and mechanism of Exos and GA combined therapy for hepatoma, providing new methods and ideas for the clinical treatment of hepatoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Liaoning University of Traditional Chinese Medicine, Liaoning Dalian China.
- College of Pharmacy, Liaoning University of Traditional Chinese Medicine, Liaoning Dalian China; Professional Innovation Technology Center for Multidimensional Analysis of Traditional Chinese Medicine, Liaoning Dalian C…
Förderung
- Scientific Research Fund of Liaoning Provincial Education Department
- Department of Education of Liaoning Province
Zitieren
APA
Zhang, Q., Han, L., Luo, X., Bao, Y., Wang, S., Li, T., Huo, J., & Meng, X. (2025). Enhancing inhibitory effect in SMMC-7721 hepatoma cells through combined treatment of gallic acid and hUC-MSCs-Exos. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.113704
Vancouver
Zhang Q, Han L, Luo X, Bao Y, Wang S, Li T, et al. Enhancing inhibitory effect in SMMC-7721 hepatoma cells through combined treatment of gallic acid and hUC-MSCs-Exos. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2024.113704
BibTeX
@article{Zhang2025,
author = {Zhang, Qiang and Han, Liying and Luo, Xi and Bao, Yongrui and Wang, Shuai and Li, Tianjiao and Huo, Jinnan and Meng, Xiansheng},
title = {Enhancing inhibitory effect in SMMC-7721 hepatoma cells through combined treatment of gallic acid and hUC-MSCs-Exos},
journal = {International Immunopharmacology},
year = {2025},
doi = {10.1016/j.intimp.2024.113704}
}
EUVIMED